ACT-1004-1239

Product Specifications

CAS Number

2178049-58-4

Target

CXCR

Related Pathways

Immunology/Inflammation|||GPCR/G Protein|||Autophagy

Purity

0.9831

Bioactivity

ACT-1004-1239 is an orally active, selective, and potent CXCR7 antagonist with immune-modulatory and myelin-promoting effects. It can be used to study inflammatory demyelinating diseases.

Smiles

N(C(=O)[C@@H]1[C@@H](NC(=O)C=2C=C(ON2)C3=C(F)C=C(F)C=C3)CCN(CC4CC4)C1)C5(CC5)C=6N=CC=CN6

Molecular Formula

C27H28F2N6O3

Molecular Weight

522.55

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

P517078 100 µg

MMP2 Protein (C-His, Human)

Ask

View Details

MR213369L3V 200 µL

Ccm2l (NM_145536) Mouse Tagged ORF Clone Lentiviral Particle

Ask

View Details

abx886210-01 10 nmol

Human hsa-miR-1193 miRNA Antagomir

Ask

View Details

abx886210-02 20 nmol

Human hsa-miR-1193 miRNA Antagomir

Ask

View Details

MBS1032994-01 0.02 mg (E-Coli)

Recombinant Shewanella halifaxensis Probable GTP-binding protein EngB (engB)

Ask

View Details

MBS1032994-02 0.1 mg (E-Coli)

Recombinant Shewanella halifaxensis Probable GTP-binding protein EngB (engB)

Ask

View Details